Strategic Analysis of Royalty Stacking for Pharmaceutical and Biopharmaceutical Products in Europe

Strategic Analysis of Royalty Stacking for Pharmaceutical and Biopharmaceutical Products in Europe

 

RELEASE DATE
28-Nov-2004
REGION
Global
Research Code: B484-01-00-00-00
SKU: HC01072-GL-MR_05106
AvailableYesPDF Download
$3,950.00
In stock
SKU
HC01072-GL-MR_05106
$3,950.00
DownloadLink
ENQUIRE NOW

Description

This strategic analysis service provides detailed analysis of royalty issues and its affects on pharmaceutical products. The service in powerpoint format (approximately 75 slides) focuses not just only on the problems with royalty stacking, patents and problems with commercialisation of biotechnology but also on strategies for resolution of these problems.

Table of Contents

Overview

  • Overview

Research Scope and Methodology

  • Research Scope and Methodology

Introduction

  • General Introduction and Background

Patent Environment

  • Patent Environment

Royalty Stacking Environment

  • Royalty Stacking Environment

Solutions to Royalty Stacking

  • Solutions to Royalty Stacking

Managing Royalties

  • Managing Royalties

Strategic Recommendations

  • Strategic Recommendations

Industry Participants

  • Industry Participants

Decision Support Databases

  • Decision Support Databases

About Frost & Sullivan

  • Our Team
  • Consulting Capabilities
This strategic analysis service provides detailed analysis of royalty issues and its affects on pharmaceutical products. The service in powerpoint format (approximately 75 slides) focuses not just only on the problems with royalty stacking, patents and problems with commercialisation of biotechnology but also on strategies for resolution of these problems.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number B484-01-00-00-00
Is Prebook No